Table 1

Baseline data for 19 475 study patients who underwent RFCA procedures stratified by indication

VariablePSVTWPWAFLAFVTP value
Number of patients12 796305118541162612
Age (years), median (IQR)47.0 (33.5, 58.6)36.3 (22.8, 49.7)62.9 (51.7, 73.1)56.9 (48.4, 65.5)43.1 (28.7, 55.2)<0.001
Age group (years)<0.001
 0–18863 (6.7)379 (12.4)15 (0.8)0 (0.0)46 (7.5)
 19–444930 (38.5)1619 (53.1)260 (14.0)216 (18.6)289 (47.2)
 45–542938 (23.0)579 (19.0)329 (17.7)285 (24.5)123 (20.1)
 55–642083 (16.3)308 (10.1)407 (22.0)354 (30.5)75 (12.3)
 65–741344 (10.5)130 (4.3)472 (25.5)222 (19.1)51 (8.3)
 75+638 (5.0)36 (1.2)371 (20.0)85 (7.3)28 (4.6)
Gender, male5402 (42.2)1988 (65.2)1332 (71.8)838 (72.1)327 (53.4)<0.001
Diabetes910 (7.1)113 (3.7)301 (16.2)134 (11.5)32 (5.2)<0.001
Hypertension1723 (13.5)275 (9.0)535 (28.9)326 (28.1)74 (12.1)<0.001
COPD286 (2.2)22 (0.7)103 (5.6)28 (2.4)15 (2.5)<0.001
CKD150 (1.2)12 (0.4)71 (3.8)11 (0.9)5 (0.8)<0.001
CAD594 (4.6)87 (2.9)288 (15.5)154 (13.3)45 (7.4)<0.001
Heart failure73 (0.6)21 (0.7)205 (11.1)53 (4.6)25 (4.1)<0.001
High-activity centre*7267 (56.8)1880 (61.6)1317 (71.0)976 (84.0)317 (51.8)<0.001
Complicated CHD10 (0.1)3 (0.1)16 (0.9)2 (0.2)1 (0.2)<0.001
TOF3 (0.0)0 (0.0)11 (0.6)1 (0.1)1 (0.2)<0.001
Other complicated CHD7 (0.1)3 (0.1)5 (0.3)1 (0.1)0 (0.0)0.045
Simple CHD †69 (0.5)31 (1.0)66 (3.6)9 (0.8)9 (1.5)<0.001
VSD15 (0.1)6 (0.2)25 (1.3)0 (0.0)4 (0.7)<0.001
ASDII50 (0.4)10 (0.3)34 (1.8)9 (0.8)4 (0.7)<0.001
Ebstein4 (0.0)18 (0.6)6 (0.3)0 (0.0)0 (0.0)<0.001
Other simple CHD4 (0.0)2 (0.1)6 (0.3)0 (0.0)1 (0.2)<0.001
  • *Defined as 100 operations per year.

  • †The discrepancy between the sums of subgroups and the total is due to the possibility that one patient might have two CHDs.

  • AF, atrial fibrillation; AFL, atrial flutter; ASD, atrial septal defect; CAD, coronary artery disease; CHD, congenital heart disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; Ebstein, Ebstein’s anomaly; PSVT, paroxysmal supraventricular tachycardia; RFCA, radiofrequency catheter ablation; TOF, Tetralogy of Fallot; VSD, ventricular septal defect; VT, ventricular tachycardia; WPW, Wolff-Parkinson-White syndrome.